Rockwell Medical (RMTI)
(Delayed Data from NSDQ)
$1.77 USD
0.00 (0.00%)
Updated Aug 7, 2024 04:00 PM ET
After-Market: $1.77 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RMTI 1.77 0.00(0.00%)
Will RMTI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RMTI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RMTI
Jushi Holdings Inc. (JUSHF) Reports Q2 Loss, Lags Revenue Estimates
TG Therapeutics (TGTX) Surpasses Q2 Earnings and Revenue Estimates
RMTI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Evolus, Inc. (EOLS) Reports Q2 Loss, Tops Revenue Estimates
Rockwell Medical (RMTI) Reports Q1 Loss, Tops Revenue Estimates
InMode (INMD) Q1 Earnings and Revenues Beat Estimates
Other News for RMTI
Rockwell Medical Q2 Earnings Preview
Rockwell Medical Launches Convenience Pack to Support Home Hemodialysis and Acute Dialysis Facilities
Rare Stock Picks In July 2024 - From 29 Discerning Analysts
Rockwell Medical Looks Like A Speculative Buy As It Approaches Profitability
Rockwell Medical to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference